Focal therapy of prostate cancer is possible using LASER, CRYOABLATION or HIFU. Currently, only focal cryoablation is reimbursed by insurance companies.
Focal laser and HIFU may be reimbursable in some cases.
In contrast to the debilitating complications associated with radical whole gland treatment by either radical surgery/robotic prostatectomy or radiation, focal therapy enabled through MRI imaging, has the ability to identify potentially lethal localized high-grade prostate cancers for eradication and potential for cure while maintaining quality of life.